TABA & SBIR/STTR Success Stories
TIV’s experts have collectively supported the commercialization of hundreds of technologies through the SBIR and STTR programs, and TABA support, spanning all participating agencies such as the NSF, DOE, and NIH. With experience working within these organizations and across academia, startups, venture capital, and R&D institutions, our team brings valuable institutional memory and a deep understanding of agency priorities. Our approach goes beyond obtaining next grant. By combining market insight and industry engagement we help innovators secure venture investment, form partnerships, and achieve tangible commercialization success. We have assisted clients at every stage, from obtaining their first SBIR award to developing IP strategy to negotiating term sheets and advancing to successful Phase III outcomes.
To see a representative selection of non‑confidential projects, please visit our Projects page.
Note: All our client engagements are subject to strict confidentiality, privacy, and conflict‑of‑interest protocols.
Find SBIR/STTR TABA Success with TIV
TABA funds fill the essential gap between technical innovation and commercial success. Our experts leverage scarce Phase I ($6,500 add-on) and Phase II (up to $50,000) allocations to deliver customized commercialization roadmaps. Learn our phase-specific approach on our TABA services page.
Other SBIR/STTR Success Stories
The SBIR and STTR programs have long been recognized as catalysts for American innovation, empowering small businesses to turn pioneering ideas into commercially successful technologies. By bridging early research with market opportunity, these programs have launched thousands of startups and strengthened the nation's innovation ecosystem. Their impact can be seen across diverse industries ranging from biotechnology and advanced materials to clean energy, communications and automation. In almost every field early SBIR/STTR support helped visionary entrepreneurs scale groundbreaking solutions.
​
One of the early beneficiaries of the SBIR program was Qualcomm, which received funding to develop satellite communication technologies. This foundational support helped Qualcomm innovate during its early stages, eventually becoming a leader in the telecommunications and semiconductor industries, particularly known for its advancements in wireless technologies. 23andMe, a personal genetics company that offers DNA testing services directly to consumers, was partly funded by an NIH SBIR grant. The company has grown significantly and is recognized for making genetic testing accessible to the public, allowing individuals to explore their ancestry and health-related genetic markers. The Roomba, an autonomous robotic vacuum cleaner, was developed by iRobot with support from an SBIR grant from the Defense Advanced Research Projects Agency (DARPA). The Roomba debuted in 2002, revolutionizing home cleaning by automating the process with a compact, intelligent device that navigates around furniture and obstacles, automatically adjusting to different floor types.
